Selected article for: "differentiation factor and granulocyte macrophage"
Author: Gómez-Rial, Jose; Rivero-Calle, Irene; Salas, Antonio; Martinón-Torres, Federico
Title: Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy
  • Cord-id: jrjgrl00
  • Document date: 2020_7_22
    • ID: jrjgrl00
    Snippet: Emerging studies from SARS-CoV-2-infected patients indicate a preponderant role of monocytes/macrophages in the pathogenesis of this viral infection, in a similar way to that previously observed in other coronavirus outbreaks (SARS and MERS). The clinical presentation of severe patients resembles viral-associated hemophagocytic syndrome, a rare condition previously seen during lethal influenza pandemics and during previous SARS and MERS coronavirus outbreaks. SARS-CoV-2 infection triggers an ove
    Document: Emerging studies from SARS-CoV-2-infected patients indicate a preponderant role of monocytes/macrophages in the pathogenesis of this viral infection, in a similar way to that previously observed in other coronavirus outbreaks (SARS and MERS). The clinical presentation of severe patients resembles viral-associated hemophagocytic syndrome, a rare condition previously seen during lethal influenza pandemics and during previous SARS and MERS coronavirus outbreaks. SARS-CoV-2 infection triggers an over-exuberant inflammatory response due to the development of a cytokine storm and the depletion of the adaptative immune compartment, which may prelude sepsis in many cases. The present review summarizes past evidence on the role of monocytes/macrophages in previous coronavirus outbreaks and the emerging knowledge on their role in COVID-19 pathogenesis. Treatment strategies incorporating the blockade of migration and differentiation of monocyte-macrophage, such as granulocyte macrophage-colony stimulating factor inhibitors, might enhance the promising results seen so far with selective cytokine blockade.

    Search related documents:
    Co phrase search for related documents
    • acute coronary syndrome and lung damage: 1, 2
    • acute coronary syndrome and lung damage respiratory failure: 1
    • acute coronary syndrome and lung injury: 1
    • acute coronary syndrome and lymphocyte count: 1, 2
    • acute inflammation and adaptive immune response: 1, 2, 3, 4
    • acute inflammation and ade antibody dependent enhancement: 1
    • acute inflammation and low expression: 1, 2
    • acute inflammation and low grade inflammation: 1, 2, 3, 4, 5
    • acute inflammation and low survival: 1
    • acute inflammation and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute inflammation and lung destruction: 1
    • acute inflammation and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • acute inflammation and lung immunopathology: 1
    • acute inflammation and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • acute inflammation and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
    • acute inflammation and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute inflammation and macrophage activation syndrome: 1, 2, 3, 4
    • acute inflammation and macrophage cell: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute inflammation and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7